Grand Rounds Recap 10.12.22


Leadership Academy- Advocacy in leadership WITH Dr. Yates and Dr. Jarrell

  • Step 1: Define Advocacy

    • Definition of advocacy: “the act or process of supporting a cause or proposal”

    • ACEP Code of Ethics for Emergency Physicians: “Principles for Ethics of Emergency Physicians #10: Emergency physicians shall support societal efforts to improve public health and safety, reduce the effects of injury and illness, and secure access to emergency and other basic health care for all.”

    • Levels of advocacy: personal, individual/patient level, departmental/institutional, governmental

  • Step 2: Identifying Stakeholders

    • Pillars of support (stakeholders) are institutions or sections of a power structure that are required in order to maintain the status quo

    • Identifying stakeholders:

      • Understand power structure within each pillar

        • Leadership team? Department? Single person?

        • Who is the spokesperson? Who makes the decisions?

      • What are the resources each stakeholder has that will help or hinder your goal?

        • Authority, human resources, skills and knowledge, materials, sanctions/punishments

  • Step 3: Spectrum of Allies

    • After determining key stakeholders in the arena that you are advocating, next you’ll need to determine the players within these pillars that are supportive, opposed, or neutral to your cause

    • Supportive: active vs passive

    • Neutral

    • Opposed: biggest area to build relationships, determine concerns, find compromises

  • Step 4: Personal Narrative

    • Define goals

      • How does your personal narrative and story convey these values and strategy?

    • Action item

      • What solution are you proposing? What does your audience need to understand about the next step?

    • Audience

      • Who is your audience? Will they relate to your story?

    • Purpose

      • What key element in your advocacy will come across better in a narrative compared to facts?

    • What constitutes a narrative?

      • Character, plot, action or choice, outcome

      • Questions to answer: Why do I care? Why now? Why should we care?

    • Pitfalls in narrative: jargon, individualized stories without broader community context, too much date, distracting story details

  • Step 5: Targeting your message

    • How you message depends on shared values

    • Strategies to reach your audience: one-on-one meetings, phone calls or emails, petitions, rallies, traditional media, social media

  • Compromise and “Failure”

    • Compromising: understand what you are willing to settle on

    • Failure

      • Where was your strongest opposition?

      • What were the biggest sticking points?

      • What groups surprised you? What groups may you be able to convince with a different story of data?

      • How do you respond?

  • Political Advocacy

    • Personal vs Professional

    • Advocacy groups to engage with:

      • Medical organizations- ACEP, AMA, state or county medical associations

      • Community organizations

      • Hospital government relations office


R3 Taming the SRU WITH Dr. Finney

Case: Middle aged male who presented to the ED with palpitation and SOB. Patient was found to be in atrial fibrillation with RVR that was later unstable, complicated alcohol withdrawal, possible new onset heart failure, and respiratory failure. 

  • Etomidate

    • Etomidate Advantages

      • Fast acting

      • Short duration of action

      • Allows good muscle relaxation for orthopedic procedures

      • Hemodynamic stability

    • Etomidate Disadvantages

      • Rapid elimination makes it suboptimal for longer procedures

      • No intrinsic analgesia

      • Higher doses can lead to adrenocortical suppression but has not been shown to be consequential

      • Myoclonus observed in up to 20% of ED patients but this rarely causes procedure failure or delay

      • Post-procedure emesis

  • Energy used for cardioversion

    • There have been varying studies for energy used in cardioversion with escalating energy (100J, 150J, 200J, 200J) and non-escalating energy protocol (200J shocks only)

    • Can start with 100J and escalate or just start at 200J

  • Anticoagulation after cardioversion

    • 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation:

      • Class I Recommendation: “For patients with AF or atrial flutter of 48 hours’ duration or longer, or when the duration of AF is unknown, anticoagulation with warfarin (INR 2.0 to 3.0), a factor Xa inhibitor, or direct thrombin inhibitor is recommended for at least 3 weeks before and at least 4 weeks after cardioversion, regardless of the CHADSVASC score or method (electrical or pharmacological) used to restore sinus rhythm.”

  • Ketamine-facilitated Intubation: using dissociative dose ketamine and atomized lidocaine for intubation over RSI method

    • Benefits:

      • Dissociation provides amnesia and analgesia while maintaining airway tone and respiratory drive

      • Can be used in uncooperative patients

    • Main concerns

      • Patient may bite down on laryngoscope and ETT

      • Increased airway tone can make laryngoscopy more challenging

      • Patient may gag, cough, and adduct vocal cords during intubation which can render ETT advancement more challenging


r4 case follow-up WITH Dr. Chuko

  • “Failure”

    • Important to recognize “failure” does occur, especially in medicine

    • Learn from these instances

    • Fixed vs growth mindset

  • Combating blindspots

    • Use aids without guilt

    • Use “when-then” and “if-then” thinking

  • Diagnostician

    • Not always possible to make a “diagnosis” in the ED

    • Important to recognize the ED does have diagnostic and therapeutic momentum


pediatric simulation: status asthmaticus WITH Cincinnati pem

  • Status asthmaticus: A prolonged and severe asthma attack that does not respond to standard treatment (bronchodilators and steroids)

  • Respiratory failure: inability to compensate resulting in hypoxia, hypercarbia or both; can be clinically defined as need for positive pressure to maintain oxygen levels >90% or pCO2 levels < 50

    • Respiratory failure is a syndrome in which the respiratory system fails in one or both of its gas exchange functions: oxygenation and carbon dioxide elimination. In practice, it may be classified as either hypoxemic or hypercapnic. 

    • Hypoxemic respiratory failure (type I) is characterized by an arterial oxygen tension (Pa O2) lower than 60 mm Hg with a normal or low arterial carbon dioxide tension (Pa CO2). This is the most common form of respiratory failure.

    • Hypercapnic respiratory failure (type II) is characterized by a PaCO2 higher than 50 mm Hg. Hypoxemia is common in patients with hypercapnic respiratory failure who are breathing room air.

      • Note: these levels are based on arterial blood gas sampling, so if I-stat or gas obtained as venous or capillary that must be taken into account

  • Aggressive medical management including:

o    IM epinephrine and/or IV terbutaline

  • Order Epi-Pen Jr (0.15 mg of epi) for patient weighing 10-25 kg (this is per the Kemp and Sicherer articles; dosing in Lexi-comp) 

    • Order Epi-Pen (0.3 mg of epi) for patients weighing 25 kg or more 

    • In kids <10 kg, use the 1:10,000 concentration IM as described in the code book (for dilution reasons) 

    • IM, not SQ – evidence supports more rapid absorption and higher plasma levels of epi when administered IM in thigh compared to SQ or IM in arm

o    IV methylprednisolone rather than prednisone/dexamethasone

o    NS fluid resuscitation: For current or anticipated hypotension from magnesium, albuterol, dehydration, or increased intrathoracic pressure from obstructive process, etc.

  • Goal: increase preload

o    Non-invasive positive pressure ventilation (NIPPV)

  • In conscious patient able to protect airway

  • Reduces WOB and energy expenditure

o    Albuterol setup in patient getting NIPPV

  • Can provide CPAP with Mapleson bag as patient breathes spontaneously while continuous albuterol is administered via T-piece

  • Similar setup works for BMV, however if patient is reclined into supine position the bag – t-piece – mask setup needs to be reorganized to prevent spillage of medication into the mouth and nose; this is the one time the green bag is physically removed from the 90-degree angle in the BVM setup

  • Risks of intubation in status asthmaticus 

o    Transition from negative to positive pressure ventilation  increased intrathoracic pressure→decreased preload→asystole

o    How to prepare for this intubation if you feel you have to: ICU consult/PICU-ED team, start epi drip prior to intubation, have backboard down and code dose epi. ketamine would be ideal sedative due to bronchodilatory effects but etomidate is appropriate; succinylcholine or rocuronium appropriate for muscular blockage.

o     In this scenario the patient would be an ECMO candidate if arrested during intubation, know where ECMO can be started and on whom at your facility

o    Indications for intubation in a severe asthma exacerbation:

  • cardiac arrest

  • respiratory arrest or profound bradypnea

  • physical exhaustion, such that NIPPV is ineffective

  • altered sensorium, such as lethargy or agitation, interfering with oxygen delivery or anti-asthma therapyText